Compare Sun Pharma with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA CIPLA SUN PHARMA/
CIPLA
 
P/E (TTM) x 29.3 28.7 102.3% View Chart
P/BV x 4.0 4.1 97.3% View Chart
Dividend Yield % 1.0 0.5 180.4%  

Financials

 SUN PHARMA   CIPLA
EQUITY SHARE DATA
    SUN PHARMA
Mar-21
CIPLA
Mar-21
SUN PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs654879 74.4%   
Low Rs339411 82.5%   
Sales per share (Unadj.) Rs139.6237.6 58.8%  
Earnings per share (Unadj.) Rs9.529.8 32.0%  
Cash flow per share (Unadj.) Rs18.242.2 43.1%  
Dividends per share (Unadj.) Rs7.505.00 150.0%  
Avg Dividend yield %1.50.8 194.9%  
Book value per share (Unadj.) Rs193.6226.7 85.4%  
Shares outstanding (eoy) m2,399.34806.46 297.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.62.7 131.0%   
Avg P/E ratio x52.121.6 240.7%  
P/CF ratio (eoy) x27.315.3 178.6%  
Price / Book Value ratio x2.62.8 90.1%  
Dividend payout %78.816.8 469.0%   
Avg Mkt Cap Rs m1,190,430519,826 229.0%   
No. of employees `000NANA-   
Total wages/salary Rs m68,62232,518 211.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m334,981191,596 174.8%  
Other income Rs m8,5922,698 318.5%   
Total revenues Rs m343,573194,294 176.8%   
Gross profit Rs m41,61641,841 99.5%  
Depreciation Rs m20,80010,031 207.3%   
Interest Rs m1,4141,607 88.0%   
Profit before tax Rs m27,99432,901 85.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,1478,888 57.9%   
Profit after tax Rs m22,84724,013 95.1%  
Gross profit margin %12.421.8 56.9%  
Effective tax rate %18.427.0 68.1%   
Net profit margin %6.812.5 54.4%  
BALANCE SHEET DATA
Current assets Rs m304,421132,095 230.5%   
Current liabilities Rs m161,45645,916 351.6%   
Net working cap to sales %42.745.0 94.9%  
Current ratio x1.92.9 65.5%  
Inventory Days Days14968 220.3%  
Debtors Days Days997 1,504.1%  
Net fixed assets Rs m336,682116,277 289.6%   
Share capital Rs m2,3991,613 148.8%   
"Free" reserves Rs m462,229181,232 255.0%   
Net worth Rs m464,628182,844 254.1%   
Long term debt Rs m8,98112,028 74.7%   
Total assets Rs m641,103248,372 258.1%  
Interest coverage x20.821.5 96.8%   
Debt to equity ratio x00.1 29.4%  
Sales to assets ratio x0.50.8 67.7%   
Return on assets %3.810.3 36.7%  
Return on equity %4.913.1 37.4%  
Return on capital %6.217.7 35.1%  
Exports to sales %031.3 0.0%   
Imports to sales %010.9 0.0%   
Exports (fob) Rs mNA59,951 0.0%   
Imports (cif) Rs mNA20,911 0.0%   
Fx inflow Rs m84,49368,051 124.2%   
Fx outflow Rs m30,33420,911 145.1%   
Net fx Rs m54,15947,140 114.9%   
CASH FLOW
From Operations Rs m61,70437,552 164.3%  
From Investments Rs m5,362-23,872 -22.5%  
From Financial Activity Rs m-59,805-13,299 449.7%  
Net Cashflow Rs m5,964509 1,171.5%  

Share Holding

Indian Promoters % 54.5 14.3 380.4%  
Foreign collaborators % 0.0 21.8 -  
Indian inst/Mut Fund % 33.8 45.8 73.8%  
FIIs % 12.1 24.8 48.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.5 63.9 71.3%  
Shareholders   675,908 410,831 164.5%  
Pledged promoter(s) holding % 6.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   AVON ORGANIC  AJANTA PHARMA  SMS PHARMA  CIAN HEALTHCARE  AAYUSH FOOD & HERBS   



Today's Market

Sensex Zooms 777 Points, Nifty Ends Above 17,400; Power & IT Stocks Rally(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

CIPLA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of CIPLA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Dec 2, 2021 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS